GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / US Biomax / Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin / Product Detail : BRC1503 Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
#BRC1503 Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Product name : Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
Catalog number : BRC1503
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin.
Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin storing antibdies for longer storage periods of the Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Breast cancer tissue array, not overlapping with BRC1501 BRC1502, 150 cores including 75 cases of normal, reactive, premalignant and malignant (various grades and stages) tissues of the breast in duplicates|
|Layout:||15 cols × 10 rows|
|Core Diameter:||1.1 mm|
|Quality Control:||H&E, IHC anti-Cytokeratin|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases_150 cores; ihc H&E, IHC anti-Cytokeratin
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1984: Integrated Breast Cancer Pathway
WP1963: The effect of Glucocorticoids on target gene expression
WP1968: genetic alternations of lung cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2263: Prostate Cancer
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2377: Integrated Pancreatic Cancer Pathway
WP1000: Arachidonate Epoxygenase Epoxide Hydrolase
WP1001: Peptide GPCRs
WP1002: Electron Transport Chain
WP1003: Ovarian Infertility Genes
WP1004: Kit Receptor Signaling Pathway
WP1005: GPCRs, Class B Secretin-like
WP1009: MAPK Cascade
WP1010: Wnt Signaling Pathway and Pluripotency
WP1011: T Cell Receptor Signaling Pathway
WP1017: Type II interferon signaling (IFNG)
WP1020: Fatty Acid Biosynthesis
WP1021: Phase I, non P450
WP1023: mRNA processing
WP1025: B Cell Receptor Signaling Pathway
WP1027: Glycolysis and Gluconeogenesis
WP1030: Selenium metabolism Selenoproteins
Related Genes :
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53)
[BRCA2 FACD FANCD1] Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[MUC1 PUM] Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]
[NRG1 GGF HGL HRGA NDF SMDF] Pro-neuregulin-1, membrane-bound isoform (Pro-NRG1) [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)]
[AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6] Aurora kinase A (EC 184.108.40.206) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)
[PTK6 BRK] Protein-tyrosine kinase 6 (EC 220.127.116.11) (Breast tumor kinase) (Tyrosine-protein kinase BRK)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 18.104.22.168) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[BCAR1 CAS CASS1 CRKAS] Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas)
[ABCG2 ABCP BCRP BCRP1 MXR] ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)
[CCAR2 DBC1 KIAA1967] Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC)
[NCOA3 AIB1 BHLHE42 RAC3 TRAM1] Nuclear receptor coactivator 3 (NCoA-3) (EC 22.214.171.124) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1)
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
[Brca2 Fancd1] Breast cancer type 2 susceptibility protein homolog (Fanconi anemia group D1 protein homolog)
[CHEK2 CDS1 CHK2 RAD53] Serine/threonine-protein kinase Chk2 (EC 126.96.36.199) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)
[ESR1 ESR NR3A1] Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
[Brca1] Breast cancer type 1 susceptibility protein homolog (EC 6.3.2.-)
[PTEN MMAC1 TEP1] Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 188.8.131.52) (EC 184.108.40.206) (EC 220.127.116.11) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)
[AKAP13 BRX HT31 LBC] A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)
[TTN] Titin (EC 18.104.22.168) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
[BCAS3] Breast carcinoma-amplified sequence 3 (GAOB1)
[NCOA6 AIB3 KIAA0181 RAP250 TRBP] Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)
[CHMP2A BC2 CHMP2] Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1)
[SGO1 SGOL1] Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1)
[ATM] Serine-protein kinase ATM (EC 22.214.171.124) (Ataxia telangiectasia mutated) (A-T mutated)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 126.96.36.199) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[PRPF31 PRP31] U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)
[SEPT9 KIAA0991 MSF] Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1)
[BRMS1] Breast cancer metastasis-suppressor 1
[MFGE8] Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin]
 Should all breast cancer patients with four or more positive lymph nodes who underwent modified radical mastectomy be treated with postoperative radiotherapy? A population-based study.
 Identification of novel prognostic indicators for triple-negative breast cancer patients through integrative analysis of cancer genomics data and protein interactome data.
 Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery.
 Diffusion-weighted breast MRI: Clinical applications and emerging techniques.
 Secretome derived from breast tumor cell lines alters the morphology of human umbilical vein endothelial cells.
 Phthalate exposure, flavonoid consumption and breast cancer risk among Mexican women.
 Amino Acid Composition of Breast Milk from Urban Chinese Mothers.
 Temporal Trends in Geographical Variation in Breast Cancer Mortality in China, 1973-2005: An Analysis of Nationwide Surveys on Cause of Death.
 Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.
 An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
Enter catalog number :